杜马斯定氮仪

Search documents
海能技术:科学仪器“小巨人”,液相色谱蓄势待发-20250609
GOLDEN SUN SECURITIES· 2025-06-09 01:08
海能技术(430476.BJ) 科学仪器"小巨人",液相色谱蓄势待发 分析仪器"小巨人",全产业链布局构筑竞争优势。公司成立于 2006 年, 专注科学仪器事业,现已形成有机元素分析、样品前处理、色谱光谱、通 用仪器四大产品系列,旗下拥有海能、新仪、G.A.S.、悟空 4 个品牌分别 主营元素分析、微波化学及样品前处理、气相色谱-离子迁移谱联用仪、液 相色谱业务。公司追求全产业链模式,减少对上游供应链的依赖,产品自 产化率、毛利率维持高水平。2024 年公司实现营收 3.1 亿元;2025Q1 实 现营收 0.55 亿元(yoy+38%)、归母净利润亏损减少,业绩恢复显著。 有机元素及样品前处理基本盘稳固,市场地位领先。1)在有机元素分析 领域,公司以凯氏定氮仪为核心构建全流程解决方案,杜马斯定氮仪成功 拓展华测检测等集团性用户,在海关系统的设备更新中也多次中标。2)在 样品前处理领域,微波消解产品在锂电等新能源、化工及石化领域销售额 24 年同比大幅增长,持续服务弗迪电池(比亚迪集团旗下品牌)、欣旺达、 中石油等知名企业。 色谱仪市场空间广阔,国产替代正当时。2019-2024 年,中国色谱仪市场 规模从 ...
海能技术(430476):科学仪器“小巨人”,液相色谱蓄势待发
GOLDEN SUN SECURITIES· 2025-06-08 12:35
有机元素及样品前处理基本盘稳固,市场地位领先。1)在有机元素分析 领域,公司以凯氏定氮仪为核心构建全流程解决方案,杜马斯定氮仪成功 拓展华测检测等集团性用户,在海关系统的设备更新中也多次中标。2)在 样品前处理领域,微波消解产品在锂电等新能源、化工及石化领域销售额 24 年同比大幅增长,持续服务弗迪电池(比亚迪集团旗下品牌)、欣旺达、 中石油等知名企业。 色谱仪市场空间广阔,国产替代正当时。2019-2024 年,中国色谱仪市场 规模从 92 亿元增长至 160 亿元左右,年均复合增长率约达 11.7%,呈现 高速扩容态势。据化工仪器网不完全统计,从中国政府采购网中标金额来 看,2025 年 1-4 月,液相色谱仪占比 38%,领跑市场;气相色谱仪以 35% 份额紧随其后。2024 年我国色谱仪国产化率仅为 16.4%,随着国产替代 进口政策支持力度加大,国产实验分析仪器市场需求将继续释放。 证券研究报告 | 首次覆盖报告 gszqdatemark 2025 06 08 年 月 日 海能技术(430476.BJ) 科学仪器"小巨人",液相色谱蓄势待发 分析仪器"小巨人",全产业链布局构筑竞争优势。公司成立于 ...
海能技术(430476):25Q1业绩超预期,看好需求回暖盈利修复
Shenwan Hongyuan Securities· 2025-05-08 09:18
Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Insights - The company reported a revenue of 310 million yuan in 2024, a decrease of 9.1% year-on-year, and a net profit of 13 million yuan, down 71.0% year-on-year, which was below expectations [7] - In Q1 2025, the company achieved a revenue of 55 million yuan, an increase of 37.8% year-on-year, although it reported a net loss of 1 million yuan [7] - The company is expected to benefit from government policies aimed at promoting equipment updates and increasing technology spending, which could lead to a recovery in demand [7][10] Financial Data and Profit Forecast - The company’s total revenue is projected to be 342 million yuan in 2025, with a year-on-year growth rate of 10.2% [6] - The net profit forecast for 2025 is 43 million yuan, representing a significant increase of 230.5% compared to 2024 [6] - The company’s gross margin is expected to be 65.6% in 2025, slightly improving from 64.3% in Q1 2025 [6] Revenue Breakdown - In 2024, the company’s revenue from organic element analysis was 104 million yuan, down 23.0% year-on-year, while sample preparation revenue was 57 million yuan, down 18.7% [7] - The chromatography and spectroscopy segment generated 79 million yuan, with liquid chromatography instruments contributing 46 million yuan, an increase of 27.2% year-on-year [7] - The company’s international revenue reached 70 million yuan in 2024, up 12.2% year-on-year, driven by expanded overseas distribution channels [7] Strategic Initiatives - The company has been investing in automation and digitalization since 2014, enhancing its manufacturing capabilities [10] - The introduction of a digital core platform in 2024 is expected to support the production of customized non-standard components [10] - The report highlights the company’s proactive approach in recruiting high-quality talent during industry downturns to ensure long-term growth [7][10]